Estimating the Direct Medical Costs and Productivity Loss of Outpatient Chlamydia and Gonorrhea Treatment. Issue 2 (February 2021)

• Record Type: Journal Article
• Authors: Kumar, Sagar; Chesson, Harrell; Gift, Thomas L.
• Is Part Of: Sexually transmitted diseases. Volume 48:Issue 2(2021)
• Publication Date: 2021-02
• Subjects: Sexually transmitted diseases -- Periodicals; Sexual health -- Periodicals; 616.951005
• DOI: 10.1097/OLQ.0000000000001240
• Languages: English
• ISSNs: 0148-5717

Abstract

Abstract : Abstract: We used 2016–2017 administrative claims data to calculate the direct medical cost and productivity loss per diagnosed case of chlamydia and gonorrhea treatment. In 2018 US dollars, the direct cost per diagnosed case was $151 for chlamydia (n = 9180) and $85 for gonorrhea (n = 3048); productivity loss was $206 (n = 31) and $246 (n = 7), respectively, among those missing work seeking care. Abstract : Using administrative claims data, we estimated medical costs to be $151 and $85 per case of chlamydia and gonorrhea, respectively. Among those missing work, productivity losses per case were higher.Supplemental digital content is available in the text.